January 20, 2022
Webinar
The answer to the question “But, is it obvious?” is of fundamental importance to the validity of Chemical and Life Sciences patents. In this seminar we will consider how this question is answered in the United States and in Europe. We will discuss how to obtain patents that have the best chance of surviving obviousness challenges.
Topics to be discussed include:
Moderator:
Anthony Tridico
Speakers:
Michele Bosch
Maeve O’Flynn
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Federal Circuit IP Blog
When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case
May 14, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.